logo

ZBIO

Zenas BioPharma·NASDAQ
--
--(--)
--
--(--)
6.28 / 10
Outperform

Analyst sentiment is bullish: three Strong Buy and one Neutral rating, weighted rating 5.01, and a 6.28 sentiment score. Fund flow scores 7.55, with positive small‑, medium‑ and large‑size inflows, though overall trend is negative.

FundamentalSentiment(6.28)Technical
Fund Flow Rating
Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

Strong Buy

75%

Buy

0%

Hold

0%

Sell

0%

Strong Sell

0%

Date2026-03-17
InstitutionMorgan Stanley
Times predicted3
Historical Win Rate33.3%
What is the market sentiment for ZBIO?
  • ZBIO holds a Bullish analyst rating, with 75% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.28/10 (Outperform).